Ophthalmic Devices are those devices which are used for vision correction or in ophthalmic diagnostic interventions. Glaucoma Surgery Devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. GlobalData uses proprietary data and analytics to provide a comprehensive report on the glaucoma surgery devices market in the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the glaucoma surgery devices market in the US was Glaukos followed by Allergan Aesthetics, New World Medical, Alcon, Johnson & Johnson Vision Care, Aurolab, Nova Eye Medical and Santen Pharmaceutical.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Glaucoma Surgery Devices include Glaucoma Drainage Devices and Minimally Invasive Glaucoma Surgery (MIGS) Devices. Glaucoma Drainage Devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow. MIGS is an ab interno procedure which is carried out using micro-incisions. MIGS Devices are usually less than 1mm
The glaucoma surgery devices market in the US can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size glaucoma surgery devices in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
